Mental Health Diagnoses among Women Experiencing Recent Intimate Partner Violence: Need for Integrated Care
Intimate partner violence (IPV) is the term used to refer to violence and abuse in various forms (including psychological, physical, sexual, financial), perpetrated by a current or former intimate partner (including spouse or other romantic or sexual partner; World Health Organization, United Nations Development Programme & United Nations Office on Drugs and Crime, 2014). In the United States, it is estimated that more than one in three women experience rape, physical violence, or stalking from an intimate partner in their lifetimes (Black et al., 2011); prevalence and incident rates vary by measurement tools and constructs measured. IPV is associated with numerous adverse outcomes, including physical injuries, chronic health conditions, trauma-related mental health symptoms, unhealthy substance use, housing instability, and suicidality.
Topiramate as Monotherapy or Adjunctive Treatment for Posttraumatic Stress Disorder: A Meta-Analysis
Topiramate, an anticonvulsant agent, has been studied as a primary and adjunctive treatment for PTSD, yet little is known regarding the efficacy of this treatment approach. The neurochemical basis for PTSD is hypothesized to involve kindling of the limbic nuclei and increased susceptibility to arousal. Anticonvulsants have been investigated as potential augmentation or monotherapy strategies to treat PTSD due to their anxiolytic and anti- kindling effects.